Conformis
-
Recon
Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
The iTotal® PS total knee replacement system is designed so that its patient-specific implants fit the unique size and shape…
Read More » -
Recon
Conformis Announces U.S. Commercial Launch of Cordera™ Match Hip System
Cordera™ Match Hip System combines the proven Cordera™ hip stem with Conformis’ state-of-the-art, personalized pre-operative plans and patient-specific instruments. BILLERICA, Mass.,…
Read More » -
Recon
Conformis Announces 510(k) Clearance for Cordera™ Hip System
BILLERICA, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS) today announced 510(k) clearance by the U.S. Food and Drug…
Read More » -
Financial
Conformis Announces Farzin Khaghani as VP, US Marketing; Inducement Grants Reported
BILLERICA, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Farzin Khaghani…
Read More » -
Financial
Conformis Reports Preliminary Second Quarter Revenue Results, Amendment to Credit Agreement
Earnings Call to be Hosted on August 5, 2020 BILLERICA, Mass., July 06, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS),…
Read More » -
Recon
Conformis Announces 510(k) Clearance for iTotal® Identity PS
BILLERICA, Mass., June 22, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug…
Read More » -
Recon
Conformis Announces Settlement of Patent Dispute
BILLERICA, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement…
Read More » -
Conformis Announces Return to Work of Furloughed Employees
BILLERICA, Mass., April 23, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) announced today that, due in large part to a…
Read More » -
Conformis Receives $4.7 Million under the Paycheck Protection Program
BILLERICA, Mass., April 20, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) today announced that on April 17, 2020 the Company…
Read More » -
COVID-19
Conformis Announces Actions to Mitigate COVID-19 Impact
BILLERICA, Mass., March 23, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), an orthopedic arthroplasty medical technology company, today announced proactive…
Read More » -
Recon
Conformis iTotal® CR Knee Replacement System Awarded “5A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom
BILLERICA, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant…
Read More » -
Recon
Conformis Appoints Bob Howe as Chief Financial Officer
BILLERICA, Mass., Feb. 05, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant…
Read More » -
Recon
Conformis Achieves 100,000 Implant Milestone for Patient-Specific Knee Replacement Technology
BILLERICA, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant…
Read More » -
Financial
Conformis Reports Preliminary Fourth Quarter and Year-End 2019 Revenue Results
BILLERICA, Mass. and SAN FRANCISCO, Jan. 14, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses…
Read More » -
Recon
Conformis Announces FDA Clearance and Full Commercial Launch of Next Generation Hip System at the 2019 AAHKS Conference
BILLERICA, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant…
Read More »